Gary Elfring
Publications by Year
Research Areas
Muscle Physiology and Disorders, Cancer therapeutics and mechanisms, Cystic Fibrosis Research Advances, Colorectal Cancer Treatments and Studies, Cardiomyopathy and Myosin Studies
Most-Cited Works
- → Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer(2000)3,003 cited
- → Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial(2017)451 cited
- → Ataluren treatment of patients with nonsense mutation dystrophinopathy(2014)426 cited
- → Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial(2008)387 cited
- → The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy(2009)386 cited
- → Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma(1999)355 cited
- → Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.(1996)352 cited
- → Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer(2007)346 cited
- → Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial(2014)334 cited
- → THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study(2013)297 cited